Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8758 |
High Similarity |
NPD4967 |
Phase 2 |
0.8758 |
High Similarity |
NPD4965 |
Approved |
0.8758 |
High Similarity |
NPD4966 |
Approved |
0.8688 |
High Similarity |
NPD37 |
Approved |
0.8623 |
High Similarity |
NPD3818 |
Discontinued |
0.8537 |
High Similarity |
NPD6234 |
Discontinued |
0.8375 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8294 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8235 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8198 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8166 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.814 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.814 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8118 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8084 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8047 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8036 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7964 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7963 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7943 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7921 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7861 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7811 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7751 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.774 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7697 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7697 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7697 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7654 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7596 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD1240 |
Approved |
0.753 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7486 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7473 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD919 |
Approved |
0.7468 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.746 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7455 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7453 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7443 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7442 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7439 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7423 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7414 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7412 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7391 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7329 |
Intermediate Similarity |
NPD943 |
Approved |
0.7326 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7322 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7322 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7306 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7303 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7299 |
Intermediate Similarity |
NPD5353 |
Approved |
0.729 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7254 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7254 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.724 |
Intermediate Similarity |
NPD6782 |
Approved |
0.724 |
Intermediate Similarity |
NPD6781 |
Approved |
0.724 |
Intermediate Similarity |
NPD6777 |
Approved |
0.724 |
Intermediate Similarity |
NPD6778 |
Approved |
0.724 |
Intermediate Similarity |
NPD6779 |
Approved |
0.724 |
Intermediate Similarity |
NPD6780 |
Approved |
0.724 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7212 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7193 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7193 |
Intermediate Similarity |
NPD920 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7167 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7151 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7135 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7128 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD1613 |
Approved |
0.711 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7095 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7076 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7066 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7062 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7029 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7029 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7018 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.6994 |
Remote Similarity |
NPD3764 |
Approved |
0.699 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD9268 |
Approved |
0.6985 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6984 |
Remote Similarity |
NPD6842 |
Approved |
0.6984 |
Remote Similarity |
NPD6841 |
Approved |
0.6984 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6979 |
Remote Similarity |
NPD6535 |
Approved |
0.6979 |
Remote Similarity |
NPD6534 |
Approved |
0.6977 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD1933 |
Approved |
0.6965 |
Remote Similarity |
NPD7801 |
Approved |
0.6964 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6946 |
Remote Similarity |
NPD7930 |
Approved |
0.6941 |
Remote Similarity |
NPD7003 |
Approved |
0.6941 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD1876 |
Approved |
0.6936 |
Remote Similarity |
NPD6273 |
Approved |
0.6931 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6927 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6915 |
Remote Similarity |
NPD7874 |
Approved |
0.6915 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.691 |
Remote Similarity |
NPD5978 |
Approved |
0.691 |
Remote Similarity |
NPD5977 |
Approved |
0.6905 |
Remote Similarity |
NPD2438 |
Suspended |
0.6905 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6901 |
Remote Similarity |
NPD2309 |
Approved |
0.6898 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6881 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6881 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD1357 |
Approved |
0.6872 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6872 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6864 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6859 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6854 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6854 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6834 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6834 |
Remote Similarity |
NPD8319 |
Approved |
0.6832 |
Remote Similarity |
NPD1283 |
Approved |
0.6813
|
Remote Similarity |
NPD3972 |
Approved |